Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
99.50
(
-0.35%
)
Bitcoin
71,146.27
(
0.53%
)
News Focus
News Focus
Post# of 12660
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

fourkids_9pets

Send PM Follow Ignore
Followers 431
Posts 57599
Boards Moderated 5
Alias Born 01/09/2007

fourkids_9pets

Re: fourkids_9pets post# 6280

Tuesday, 04/28/2009 1:54:34 PM

Tuesday, April 28, 2009 1:54:34 PM

Post# of 12660
this blurb is from fidelity
who got it from fly on the wall

<latest>

--
Dendreon options suggests risk trading halt into Prostate data
1:34 p.m. 04/28/2009 Provided By Fly On The Wall
Dendreon (DNDN) is halted down $9.57 at $11.98 on news pending. DNDN will report detailed Phase 3 IMPACT (Immunotherapy for Prostate AdenoCarcinoma Treatment) this afternoon. DNDN call option volume of 106,640 contracts compares to put volume of 56,213 contracts according to Track Data.

--
4kids
all jmo

10/5/07 -- there are no coincidences here ...
oh and like many other longs .. not selling at this level --

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today